Blood Transfusions in Thalassemia Patients, Complications and Adverse Effects
NCT00971880 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2011-08-26
Summary
Patients suffering from Thalassemia or another hemoglobinopathies required regular blood transfusions. The complications and adverse effects of blood transfusions can be classified as immediate and late. Among the immediate effects the most common are allergic reactions and fever, besides congestive heart failure in patients with cardiomyopathy. The late effects are mostly related to blood transmitted infections like HIV or Hepatitis C infections.
The purpose of this study is to summarize the data of those complications in a cohort of 100 patients receiving regular blood transfusion.
Conditions
Interventions
- OTHER
-
Clinical medical record summary
Summary of immediate and late adverse effects of blood transfusions
Sponsors & Collaborators
-
HaEmek Medical Center, Israel
lead OTHER
Eligibility
- Min Age
- 1 Month
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-31
- Primary Completion
- 2010-11-30
- Completion
- 2010-11-30
Countries
- Israel
Study Locations
More Related Trials
-
Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
NCT01996683 ·Status: UNKNOWN ·Phase: NA
-
Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
NCT00736060 ·Status: COMPLETED
-
Iron Overload and Growth Velocity in Thalassemia and Sickle Cell Anemia
NCT00972231 ·Status: COMPLETED
-
The Spleen in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00971698 ·Status: COMPLETED
-
Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia
NCT01443312 ·Status: COMPLETED
-
Pharmacotherapy Prescribing Pattern and the Adherence Level to Iron Chelation Therapy in Thalassemia
NCT06210139 ·Status: COMPLETED
-
Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00512226 ·Status: COMPLETED ·Phase: NA
-
Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel
NCT00971984 ·Status: COMPLETED
-
Complications in Children With B- Thalassemia Major
NCT03462784 ·Status: UNKNOWN
-
Congenital Heart Surgery in Pediatric Patients With Beta-Thalassemia Major
NCT04367701 ·Status: COMPLETED
-
Iron Status in BTM With Blood Transfusion
NCT04947540 ·Status: UNKNOWN
-
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study
NCT00661804 ·Status: COMPLETED
-
Quality of Life and Treatment Satisfaction in β-Thalassemia Patients Receiving Deferasirox
NCT03358498 ·Status: UNKNOWN
-
Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus
NCT03851055 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia
NCT03651102 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Beta-thalassemia and Microparticles
NCT01284738 ·Status: COMPLETED ·Phase: NA
-
Adherence of Beta Thalssemia Patients to Oral Chelation Therapy
NCT06568926 ·Status: RECRUITING ·Phase: NA
-
Dermatological Abnormalities in Beta-thalassemia Major
NCT03894605 ·Status: UNKNOWN
-
Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)
NCT00001958 ·Status: COMPLETED ·Phase: PHASE2
-
B-Thalasaemia Trait and Its Possible Cardioprotective Role
NCT02428023 ·Status: UNKNOWN
-
Effect of Metoprolol on Thalassemia Cardiomyopathy
NCT01863173 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
NCT00171171 ·Status: COMPLETED ·Phase: PHASE3
-
Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major
NCT01752153 ·Status: COMPLETED ·Phase: PHASE1
-
Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major
NCT02761395 ·Status: UNKNOWN ·Phase: NA
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA